Kobayashi Pharmaceutical Co. Ltd. reported consolidated earnings results for the nine months ended December 31, 2012. For the period, the company reported net sales of ¥94,828 million compared to ¥102,736 million a year ago. Operating income was ¥14,615 million compared to ¥16,743 million a year ago. Ordinary income was ¥15,968 million compared to ¥17,185 million a year ago. Net income was ¥11,606 million or ¥283.44 per share compared to ¥9,473 million or ¥231.35 per share a year ago. Income before income taxes was ¥17,563 million compared to ¥16,207 million a year ago.

The company revised earnings guidance for the full year ending March 31, 2013. For the period, the company expects net sales of ¥122,000 million, operating income of ¥16,800 million, ordinary income of ¥18,300 million and net income of ¥12,300 million or ¥300.38 per share.

The company forecasts dividend of ¥43.00 per share for the year ending March 31, 2013 compared to ¥43 for the same period a year ago.